FDA dropped the meeting rules for drug makers
The FDA just finalized binding response timelines of 30 to 75 days for pharmaceutical companies seeking official guidance on new drugs.
By Foodie Pundit Newsroom - Published - Updated - Section: Policy Regulation
Key points
- A new FDA guidance shows how drug sponsors will interact with regulators about new products.
This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.